Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
A Look at the Long-Term Data on a Therapy for Virologically Suppressed Adults
A Look at the Long-Term Data on a Therapy for Virologically Suppressed Adults
The Importance of Pursuing Novel Treatments for Major Depressive Disorder
The Importance of Pursuing Novel Treatments for Major Depressive Disorder
Exploring the Use of Peptide-Based Formulas in Enteral Nutrition Therapy
Exploring the Use of Peptide-Based Formulas in Enteral Nutrition Therapy
Updates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Updates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Real-World Case Studies and Clinical Considerations for a Procedural Sedative Metabolized by Tissue Esterases
Real-World Case Studies and Clinical Considerations for a Procedural Sedative Metabolized by Tissue Esterases
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
The Four-Hit Model of IgA Nephropathy Pathogenesis
The Four-Hit Model of IgA Nephropathy Pathogenesis
A Step Toward Pain Relief: Targeted Care for Painful Diabetic Peripheral Neuropathy of the Feet
A Step Toward Pain Relief: Targeted Care for Painful Diabetic Peripheral Neuropathy of the Feet
The Complement System in the Pathogenesis of IgA Nephropathy
The Complement System in the Pathogenesis of IgA Nephropathy
A Review of Kidney Biopsy in Complement-Mediated Kidney Diseases
A Review of Kidney Biopsy in Complement-Mediated Kidney Diseases
Managing BPDCN as a Targeted Treatment Option
Managing BPDCN as a Targeted Treatment Option
An Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies
An Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies
Advances in BPDCN Treatment: Targeting Its Pathophysiology
Advances in BPDCN Treatment: Targeting Its Pathophysiology
Implementing LDL-C—Lowering Therapy: Conversations with the Care Team
Implementing LDL-C—Lowering Therapy: Conversations with the Care Team
Testing Your Ovarian Cancer Patients for Homologous Recombination Deficiency
Testing Your Ovarian Cancer Patients for Homologous Recombination Deficiency